![Gsk, 113 milioni di investimenti per il biotech di Parma (anche per la lotta contro il Covid)- Corriere.it Gsk, 113 milioni di investimenti per il biotech di Parma (anche per la lotta contro il Covid)- Corriere.it](https://images2.corriereobjects.it/methode_image/socialshare/2020/12/07/3d55a882-3890-11eb-a3d9-f53ec54e3a0b.jpg)
Gsk, 113 milioni di investimenti per il biotech di Parma (anche per la lotta contro il Covid)- Corriere.it
![San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV](https://c8.alamy.com/comp/PW64TM/san-polo-di-torrile-italy-12th-october-2018-sunight-is-enlightening-gsk-logo-on-plant-for-innovative-anti-hiv-drug-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW64TM.jpg)
San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV
![San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV San Polo di Torrile, Italy. 12th October, 2018. Sunight is enlightening GSK logo on plant for innovative anti-HIV drug. GSK will produce Fostemsavir on behalf of ViiV Healthcare, the global specialist HIV](https://c8.alamy.com/comp/PW8WDW/san-polo-di-torrile-italy-12th-october-2018-sunight-is-enlightening-gsk-logo-on-plant-for-innovative-anti-hiv-drug-gsk-will-produce-fostemsavir-on-behalf-of-viiv-healthcare-the-global-specialist-hiv-company-majority-owned-by-glaxosmithkline-with-pfizer-inc-and-shionogi-limited-as-shareholders-gonewiththewindalamy-live-news-PW8WDW.jpg)